NasdaqCM - Nasdaq Real Time Price • USD
Celldex Therapeutics, Inc. (CLDX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
CAVANAUGH SARAH Officer | Sale | Aug 18, 2022 | 1,284 |
CROWLEY ELIZABETH Officer | Sale | Dec 8, 2021 | 4,726 |
HEATH-CHIOZZI MARGO Officer | Sale | Dec 8, 2021 | 11,247 |
JIMENEZ FREDDY A General Counsel | Conversion of Exercise of derivative security | Feb 13, 2024 | 25,924 |
KELER TIBOR Officer | Sale | Dec 7, 2022 | 7,357 |
MARINO JAMES J Director | Purchase | Jun 9, 2020 | 12,704 |
MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security | Jan 2, 2024 | 35,128 |
MARUCCI ANTHONY S Chief Executive Officer | Sale | Aug 15, 2022 | 27,692 |
WRIGHT RICHARD M Officer | Sale | Aug 15, 2022 | 208 |
YOUNG DIANE C Officer | Sale | Aug 17, 2022 | 47,115 |
Related Tickers
MRUS Merus N.V.
45.04
+0.24%
MLTX MoonLake Immunotherapeutics
42.49
+0.57%
DNTH Dianthus Therapeutics, Inc.
21.50
+2.43%
ATXS Astria Therapeutics, Inc.
9.00
-1.85%
JSPR Jasper Therapeutics, Inc.
20.40
-3.68%
KPTI Karyopharm Therapeutics Inc.
1.0600
0.00%
IMVT Immunovant, Inc.
27.17
-2.09%
VERA Vera Therapeutics, Inc.
39.65
+2.48%
CABA Cabaletta Bio, Inc.
11.01
-9.61%
AFMD Affimed N.V.
5.03
+3.07%